Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Gerdts

Showing results (131-140 of 262) with videos related to

Pageof 27
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 19, 2002
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) StudyEva Gerdts, Lasse Oikarinen, Vittorio Palmieri, et al.
JACC. Advances|January 29, 2025
Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø StudyHilde Espnes, Tom Wilsgaard, Jocasta Ball, et al.
Echocardiography (Mount Kisco, N.Y.)|August 6, 2023
Impact of aortic valve stenosis on myocardial deformation in different left ventricular levels: A three-dimensional speckle tracking echocardiography studyJohannes Just Hjertaas, Eigir Einarsen, Eva Gerdts, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 1, 2020
Left ventricular myocardial oxygen demand and subclinical dysfunction in patients with severe obesity referred for bariatric surgeryLisa M D Grymyr, Saied Nadirpour, Eva Gerdts, et al.
Journal of the American College of Cardiology|June 18, 2013
Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis)Barbara P Rogge, Dana Cramariuc, Mai Tone Lønnebakken, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 17, 2009
Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE studyKurt Boman, Eva Gerdts, Kristian Wachtell, et al.
Journal of Hypertension|May 21, 2010
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension studySilvana Cicala, Giovanni de Simone, Eva Gerdts, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|October 27, 2025
Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart studyAnja Linde, Eva Gerdts, Bjørg T Fevang, et al.
Trends in Molecular Medicine|October 8, 2023
Multiomics tools for improved atherosclerotic cardiovascular disease managementMiron Sopic, Baiba Vilne, Eva Gerdts, et al.
American Journal of Hypertension|June 29, 2023
Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE StudyJoshua B Feinberg, Emil E Nielsen, Sverre E Kjeldsen, et al.
Pageof 27

Showing results (131-140 of 262) with videos related to

Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|March 19, 2002
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) StudyEva Gerdts, Lasse Oikarinen, Vittorio Palmieri, et al.
JACC. Advances|January 29, 2025
Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø StudyHilde Espnes, Tom Wilsgaard, Jocasta Ball, et al.
Echocardiography (Mount Kisco, N.Y.)|August 6, 2023
Impact of aortic valve stenosis on myocardial deformation in different left ventricular levels: A three-dimensional speckle tracking echocardiography studyJohannes Just Hjertaas, Eigir Einarsen, Eva Gerdts, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 1, 2020
Left ventricular myocardial oxygen demand and subclinical dysfunction in patients with severe obesity referred for bariatric surgeryLisa M D Grymyr, Saied Nadirpour, Eva Gerdts, et al.
Journal of the American College of Cardiology|June 18, 2013
Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis)Barbara P Rogge, Dana Cramariuc, Mai Tone Lønnebakken, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 17, 2009
Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE studyKurt Boman, Eva Gerdts, Kristian Wachtell, et al.
Journal of Hypertension|May 21, 2010
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension studySilvana Cicala, Giovanni de Simone, Eva Gerdts, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|October 27, 2025
Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart studyAnja Linde, Eva Gerdts, Bjørg T Fevang, et al.
Trends in Molecular Medicine|October 8, 2023
Multiomics tools for improved atherosclerotic cardiovascular disease managementMiron Sopic, Baiba Vilne, Eva Gerdts, et al.
American Journal of Hypertension|June 29, 2023
Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE StudyJoshua B Feinberg, Emil E Nielsen, Sverre E Kjeldsen, et al.
Pageof 27